Laura D’Alimonte

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes

Andrew Loblaw, Patrick Cheung, Laura D’Alimonte et al. · Radiotherapy and Oncology · 2013 · 164 citations

Urology, Radiation Medicine, Radiation Therapy +8

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy

Gerard Morton, Hans T. Chung, Merrylee McGuffin et al. · Radiotherapy and Oncology · 2016 · 87 citations

Radiation Therapy, Medicine, Brachytherapy +5

Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial

Jure Murgić, Gerard Morton, Andrew Loblaw et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 68 citations

Urology, Surgical Oncology, Radiation Medicine +6

Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials

Hima Bindu Musunuru, Harvey Quon, Melanie Davidson et al. · Radiotherapy and Oncology · 2016 · 64 citations

Urology, Medicine, Brachytherapy +7

Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life

Hima Bindu Musunuru, Laura D’Alimonte, Melanie Davidson et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 59 citations

Radiation Medicine, High-risk Prostate Cancer, Radiation Therapy +10